Skip to main content

STIFEL FINANCIAL CORP

Position in BEAM — Beam Therapeutics Inc.

CIK 720672 ST. LOUIS, MO

Position in BEAM

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$582,719
+$286,871 QoQ
Shares Held
16,979
+36.8% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#132
of 274 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in BEAM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $537,727,692 across 104 Biotechnology names. BEAM ranks #59 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BEAM

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $582,719 16,979
2026-03-31 $295,848 12,415
2025-12-31 $371,585 13,405
2025-09-30 $301,917 12,440
2025-06-30 $184,404 10,841
2025-03-31 $221,743 11,354
2024-12-31 $338,816 13,662
2024-09-30 $261,807 10,686
2024-03-31 $251,961 7,626
2023-06-30 $216,389 6,777
2023-03-31 $215,013 7,022
2022-12-31 $261,411 6,684
2022-09-30 $456,581 9,584
2022-03-31 $243,009 4,241
2021-12-31 $332,626 4,174
2021-09-30 $272,341 3,130